Bajaj Healthcare logo

Bajaj Healthcare financials and balance sheet

NSE: BAJAJHCAREBSE: 539872Pharmaceuticals & BiotechnologySmall Cap

Last close ₹312.60down ₹12.05 (3.71%)BSE ₹312.65

Share price at the NSE close on 23 Oct 2026. Previous close ₹324.65.

52-week range of traded prices to 23 Oct 2026
₹272.35Low, 18 May 2026₹488.90High, 30 Oct 2025
Market cap
₹1,052 Cr1,450th largest listed
P/E
51.0
P/E without one-offs
18.1
P/B
1.9
Dividend yield
0.48%
ROE
4.0%
ROE without one-offs
11.2%
ROCE
10.2%
Debt to equity
0.48
Volume, NSE
1,96,73947.7% delivered

10 years at a glance

Standalone: the listed company alone, without its subsidiaries. ₹ crore, years to March.Bajaj Healthcare annual reports

Revenue, net profit and borrowings, ₹ crore

  • Revenue
  • Net profit
  • Borrowings
  • Loss
A loss in 1 of the 10 years shown

Operating and net margin, per cent

  • Operating margin
  • Net margin

From Apr 2019 leases sit on the balance sheet: rent is charged as depreciation and interest instead, so operating profit and total assets step up with nothing about the business having changed. Borrowings here leave lease liabilities out. Lease payments were 0.3% of operating profit in the first full year.

The years either side of a change of basis do not compare. From the year to Mar 2024, the company reports a discontinued business.

Results for the year to Mar 2026

Standalone: the listed company alone, without its subsidiaries. ₹ crore.

From revenue to net profit

  1. Revenue611
  2. Materials and goods−316
  3. Employee costs−63
  4. Other expenses−127
  5. Operating profit105
  6. Depreciation−28
  7. Other income+7.1
  8. One-off items−33
  9. Finance costs−22
  10. Profit before tax29
  11. Tax−7.6
  12. Discontinued businesses−5.5
  13. Net profit16

What the company owns

  • Plant, investments and other assets₹435 Cr
  • Receivables₹234 Cr
  • Inventory₹216 Cr
  • Cash and bank₹38 Cr

What pays for it: net worth and liabilities

  • Net worth₹533 Cr
  • Borrowings₹233 Cr
  • Owed to suppliers₹115 Cr
  • Other liabilities₹41 Cr

Profit and loss

Standalone, ₹ crore, years to March.Bajaj Healthcare quarterly results

₹ croreMar 2017Mar 2018Mar 2019Filed 14 JunMar 2020Filed 4 JulMar 2021Filed 10 JunMar 2022Filed 21 MayMar 2023Filed 31 MayMar 2024Filed 14 JunMar 2025Filed 12 JunMar 2026Filed 8 May
Revenue from operations231327370410657680673473543611
200288––521561566397460506
Materials and goods bought171256288315464496491255286316
Employee costs–22––354148445763
Other expenses–10––22242899117127
Operating profit before depreciation3139––1361191077682105
Operating margin13.3%12.0%––20.8%17.4%15.9%16.1%15.2%17.2%
Materials, % of revenue–78.3%––70.6%73.0%72.9%53.8%52.8%51.8%
Employee costs, % of revenue–6.6%––5.3%6.0%7.1%9.3%10.5%10.3%
Other expenses, % of revenue–3.1%––3.3%3.6%4.2%20.8%21.5%20.8%
Depreciation and amortisation1111––161827282828
Operating profit after depreciation1928––12010179495577
Other income22137129197
Finance costs888681323302822
Profit before one-off items and tax142324321199058284662
One-off items––––000−440−33
Profit before tax142324321199058−174629
67810361815−238
Profit from discontinued businesses–––––––−69−3−6
Net profit8151622837143−843916
Other comprehensive income––––000−311
Total comprehensive income––––837143−874116
Net margin3.4%4.6%4.4%5.5%12.7%10.5%6.4%–7.3%–
Materials, employee costs and other expenses are shown for the years they add up to operating expenses; for the year to Mar 2017 they do not, so they are left blank. Operating expenses, operating profit before depreciation and operating profit after depreciation are left blank for the years to Mar 2019 and Mar 2020: the statement does not state its depreciation, which operating profit is worked out from, so operating profit is not given. Net margin is left blank for the years to Mar 2024 and Mar 2026: the profit includes the result of a business the company has discontinued, which the revenue does not, so the two make no margin.

Balance sheet

Standalone, ₹ crore, at 31 March. The last column is the half year to Sep 2026, after the latest full year: the balance sheet at its end.

₹ croreMar 2019Filed 14 JunMar 2020Filed 4 JulMar 2021Filed 10 JunMar 2022Filed 21 MayMar 2023Filed 31 MayMar 2024Filed 14 JunMar 2025Filed 12 JunMar 2026Filed 8 MaySep 2026Half yearFiled 17 Oct
129152258328368278466533557
Share capital71414141414161717
Reserves122138245315354265450516540
7282168257414332223233268
117146183322436376272320324
202885719872705889
Liabilities going with businesses held for sale–––––39251310
267326526721901765833923981
130145267323392284272284337
137181258398510406485569572
Net debt6478154255397329218195253
Borrowings are counted again inside the liabilities due within a year and after a year. Plant in use and plant being built are given for full years only. No balance sheet is on record for the years to Mar 2017 and Mar 2018, so its lines and the ratios worked from it are blank there.

Cash flow

Standalone, ₹ crore, years to March. The last column is the half year to Sep 2026, after the latest full year: the cash flow over its six months.

₹ croreMar 2021Filed 10 JunMar 2022Filed 21 MayMar 2023Filed 31 MayMar 2024Filed 14 JunMar 2025Filed 12 JunMar 2026Filed 8 MaySep 2026Half yearFiled 17 Oct
441−2292225816
7110−11105265616
−64−109−12039−63−48−47
Receivables0−86−4713−6821−22
Inventories−58−62−5020−18−54−21
Payables000000−4
Other working capital−739−23523−15−1
Tax paid−36−10−12−13−52−1
Interest paid8000000
Capital spending114749430124361
Free cash flow−70−74−116621015−45
−109−75−93−11−15−48−53
7562131−97−62414
Dividends paid2143335
Shares bought back0000000
Shares issued0000150530
Net change in cash10−1216−16035−24
Capital spending is part of cash from investing, and dividends paid, shares bought back and shares issued are part of cash from financing. Each is shown as an amount on a line of its own, and the section's other items are in its total only. No cash flow statement is on record for the years to Mar 2017, Mar 2018, Mar 2019 and Mar 2020.

Per share

Standalone, ₹ per share, years to March.Bajaj Healthcare dividend history

₹ per shareMar 2017Mar 2018Mar 2019Filed 14 JunMar 2020Filed 4 JulMar 2021Filed 10 JunMar 2022Filed 21 MayMar 2023Filed 31 MayMar 2024Filed 14 JunMar 2025Filed 12 JunMar 2026Filed 8 May
–––––₹25.87₹15.59−₹30.36₹13.29₹4.98
As stated that year₹11.37₹22.01₹23.64₹16.31₹60.23₹25.87₹15.59−₹30.36₹13.29₹4.98
–––––₹25.87₹15.59−₹30.36₹13.12₹4.97
Dividend per share–––––₹1.50₹1.00₹1.00₹1.00₹1.50
–––––₹119.02₹133.23₹100.86₹147.60₹158.34
Dividend payout–––––5.8%6.4%–8.0%32.0%
Shareholder yield––––0.4%0.1%0.5%0.3%−6.9%−5.1%
Market cap at the year end (₹ crore)2242762932846519408478072,117977
Every year is restated for later splits and bonuses, so they do not break the line. The figure the company stated that year is under each line it differs from.

Ratios

Standalone, years to March.Bajaj Healthcare PE ratio and valuation

RatioMar 2017Mar 2018Mar 2019Filed 14 JunMar 2020Filed 4 JulMar 2021Filed 10 JunMar 2022Filed 21 MayMar 2023Filed 31 MayMar 2024Filed 14 JunMar 2025Filed 12 JunMar 2026Filed 8 May
Revenue growth3.5%41.8%13.2%10.8%60.2%3.5%−1.0%–14.6%12.6%
Operating profit growth–28.0%–––−13.1%−9.8%–8.1%27.2%
Net profit growth−4.6%94.1%7.4%37.9%269.4%−14.1%−39.7%––−60.1%
Earnings per share growth––––––−39.7%––−62.5%
––12.6%16.0%40.5%24.3%12.4%−25.9%10.6%3.2%
–––3.4 pts24.5 pts−16.2 pts−12.0 pts−38.3 pts36.5 pts−7.5 pts
From the net margin–––3.1 pts20.9 pts−6.9 pts−9.5 pts–––
From asset turnover–––0.0 pts4.3 pts−9.9 pts−3.5 pts–––
From borrowing–––0.3 pts−0.7 pts0.5 pts1.1 pts–––
Return on capital employed––––28.2%17.2%10.2%8.0%7.9%10.1%
Cash conversion––––52.4%1.0%−51.9%–54.7%368.4%
Interest cover2.43.7––14.58.03.51.62.03.5
Debt to equity––0.560.540.650.781.131.190.480.44
Receivable days––77895599123139169140
Inventory days––384576117155206206249
Payable days––––547763128122133
Cash conversion cycle, days––––77139216217254256
Working capital days––667983142204227247237
Asset turnover––1.391.381.541.090.830.570.680.70
Assets per rupee of net worth––2.072.112.082.122.332.582.151.76
Sales per rupee of plant––2.852.933.162.521.841.882.292.47
Capital spending to depreciation––––7.064.213.421.100.411.57
Plant being built, % of plant in use––––27.4%19.3%5.9%1.9%1.5%3.2%
From the net margin, from asset turnover and from borrowing are left blank for the years to Mar 2024, Mar 2025 and Mar 2026: the profit of this year or the year before includes a business the company has discontinued while its revenue does not, so the change in return on equity is not split into margin, turnover and borrowing. Revenue growth and operating profit growth are left blank for the year to Mar 2024: between the two periods the company began reporting a business as discontinued, so the two are on different bases and the change is not worked out. No balance sheet is on record for the years to Mar 2017 and Mar 2018, so its lines and the ratios worked from it are blank there.

Growth and returns over 3, 5 and 10 years

Standalone: the listed company alone, without its subsidiaries. Each window ends with the year to Mar 2026.

Return on assets, latest year
1.8%
Cash from operations against operating profit
55.4%
Measure10 years5 years3 years
Revenue growth, yearly rate10.6%−1.4%−3.2%
Profit growth, yearly rate6.8%−28.3%−28.4%
Return on equity, average–4.9%−4.1%
Return on capital employed, average–10.7%8.7%
Operating margin, average–16.4%16.2%
Asset turnover, average–0.770.65
Cash conversion cycle, days, average–216242
Interest cover, average–3.72.4
Debt to equity, average–0.800.70

Where the cash came from and went

Standalone: the listed company alone, without its subsidiaries. ₹ crore, added up over each window, which ends with the year to Mar 2026.

₹ crore5 years3 yearsLatest year
Cash from operations15017258
Cash from investing−242−74−48
Cash from financing115−7924
Capital spending2538543
Dividends paid1493
Shares bought back000
Shares issued for cash20220253
Borrowings raised247461
Borrowings repaid2802231

Accounting checks

Standalone, years to March. Published tests of whether reported profit is backed by cash and the balance sheet.

CheckMar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Piotroski score, out of 9Published threshold 3 points out of 9–––––43576
Altman Z-scorePublished threshold 1.81––––4.333.592.642.205.473.45
Beneish M-scorePublished threshold −1.78–––––−1.41−2.27−2.25−1.96−2.77
Profit not backed by cash, % of assetsPublished threshold 10 per cent of average total assets––––34.8823.3419.57−19.784.090.62
Cash from operations to profit, 3 yearsPublished threshold 0.7 times––––––0.112.31––
Receivables growth less revenue growthOur threshold 0 percentage points–––17.41−61.4883.1124.228.9425.02−19.69
Inventory growth less cost-of-goods growthOur threshold 0 percentage points–––21.28100.0057.1232.1817.06−0.0422.98
Other current assets growth less revenue growthOur threshold 5 per cent of revenue–––3.871.690.660.484.79−2.042.27
Assets under construction, years of additionsOur threshold 2 years of additions–––––0.660.18–0.280.21
Effective tax ratePublished threshold 17.16 per cent42.8433.0532.5230.6730.0520.4026.10–6.6926.32
Tax charged less tax paid, % of profitOur threshold 10 percentage points–––––9.666.28–−3.2819.33
A threshold marked as ours has no published figure; it is the line we read the check against.

Credit ratings

An agency's view of the chance the company repays a borrowing on time, from AAA, the highest, down to D, in default.

DateAgencyBorrowing ratedRatingOutlookAmount, ₹ Cr
6 Aug 2026India Ratings and Research Private Limited (opens in a new tab)Bank loan facilitiesIND A; IND A1Review, UpgradeStable282
The latest rating on each borrowing. The agency's name opens its reasoning for the rating.